We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNL icon
401
Broadstone Net Lease
BNL
$4.12B
$54.4K ﹤0.01%
3,132
-16
-0.5% -$288
SLG icon
402
SL Green Realty
SLG
$3.81B
$54.1K ﹤0.01%
1,179
-6
-0.5% -$296
CDP icon
403
COPT Defense Properties
CDP
$4.35B
$52.2K ﹤0.01%
1,877
-9
-0.5% -$259
EWTX icon
404
Edgewise Therapeutics
EWTX
$4.42B
$51.6K ﹤0.01%
2,079
-187
-8% -$3.75K
OCUL icon
405
Ocular Therapeutix
OCUL
$1.85B
$50.8K ﹤0.01%
4,185
+442
+12% +$5.37K
SYRE icon
406
Spyre Therapeutics
SYRE
$8.81B
$49.9K ﹤0.01%
1,523
+224
+17% +$5.85K
U icon
407
Unity
U
$14.6B
$49.8K ﹤0.01%
+1,128
New +$46K
ADPT icon
408
Adaptive Biotechnologies
ADPT
$3.87B
$48.7K ﹤0.01%
2,998
-278
-8% -$4.54K
LXP icon
409
LXP Industrial Trust
LXP
$3.52B
$48.7K ﹤0.01%
982
-5
-0.5% -$240
DNLI icon
410
Denali Therapeutics
DNLI
$3.86B
$47.6K ﹤0.01%
2,881
-265
-8% -$4.47K
CNTA
411
DELISTED
Centessa Pharmaceuticals
CNTA
$47.4K ﹤0.01%
1,895
-169
-8% -$4.28K
HIW icon
412
Highwoods Properties
HIW
$3.73B
$46.1K ﹤0.01%
1,786
-9
-0.5% -$254
AKR icon
413
Acadia Realty Trust
AKR
$3.08B
$44.5K ﹤0.01%
2,168
-11
-0.5% -$219
APLE icon
414
Apple Hospitality REIT
APLE
$3.92B
$44.4K ﹤0.01%
3,745
-19
-0.5% -$223
SRPT icon
415
Sarepta Therapeutics
SRPT
$1.64B
$44.3K ﹤0.01%
2,059
-43
-2% -$906
ASTS icon
416
AST SpaceMobile
ASTS
$17.5B
$44K ﹤0.01%
+606
New +$43.2K
RARE icon
417
Ultragenyx Pharmaceutical
RARE
$2.56B
$43.6K ﹤0.01%
1,895
-178
-9% -$5.85K
XPEV icon
418
XPeng
XPEV
$12.4B
$42.3K ﹤0.01%
2,088
-476,867
-100% -$10.3M
MPT
419
Medical Properties Trust
MPT
$2.81B
$42.3K ﹤0.01%
8,466
+6
+0.1% +$31
HRMY icon
420
Harmony Biosciences
HRMY
$2.08B
$42.3K ﹤0.01%
1,131
-107
-9% -$3.52K
RXRX icon
421
Recursion Pharmaceuticals
RXRX
$1.61B
$41.3K ﹤0.01%
10,104
+911
+10% +$4.51K
AUPH icon
422
Aurinia Pharmaceuticals
AUPH
$1.93B
$41.3K ﹤0.01%
2,590
-242
-9% -$3.43K
UE icon
423
Urban Edge Properties
UE
$2.87B
$40K ﹤0.01%
2,084
+7
+0.3% +$136
FCPT icon
424
Four Corners Property Trust
FCPT
$2.8B
$39.9K ﹤0.01%
1,731
+54
+3% +$1.29K
LINE
425
Lineage Inc
LINE
$9.76B
$39.8K ﹤0.01%
1,137
-20
-2% -$739
15 16
17
18 19

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.